BAUSCH + LOMB CORP (BLCO.CA) Stock News
TSX:BLCO - Toronto Stock Exchange - CA0717051076 - Common Stock - Currency: CAD
BLCO.CA Latest News and Analysis
All
Press Releases
7 days ago - Bausch + Lomb Corporation
Bausch + Lomb Provides Update on Potential Sale
22 days ago - Bausch + Lomb Corporation
Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2024 Financial Results on February 19
a month ago - Bausch + Lomb Corporation
Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences
a month ago - Bausch + Lomb Corporation
Bausch + Lomb Launches enVista Aspire™ Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European Union
a month ago - Bausch + Lomb Corporation
Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual “Faces of Glaucoma” Campaign and Fundraising Challenge
a month ago - Bausch + Lomb Corporation
Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
2 months ago - Bausch + Lomb Corporation
Bausch + Lomb Responds to Rumors of a Potential Sale
2 months ago - Bausch + Lomb Corporation
Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities
4 months ago - Bausch + Lomb Corporation
Bausch + Lomb Announces Third-Quarter 2024 Results
4 months ago - Bausch + Lomb Corporation
Bausch + Lomb Receives FDA Approval for enVista® Envy™ Full Range of Vision Intraocular Lens
4 months ago - Bausch + Lomb Corporation
Bausch + Lomb Will Release Third-Quarter 2024 Financial Results on October 30
4 months ago - Bausch + Lomb Corporation
Bausch + Lomb Launches Opal™ Digital Marketplace in the United States
7 months ago - Bausch + Lomb Corporation
Bausch + Lomb Announces Second-Quarter 2024 Results
7 months ago - Bausch + Lomb Corporation
Bausch + Lomb Will Release Second-Quarter 2024 Financial Results on July 31
7 months ago - Bausch + Lomb Corporation
Millions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find Relief
8 months ago - Bausch + Lomb Corporation
Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress
8 months ago - Bausch + Lomb Corporation
Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States
8 months ago - Bausch + Lomb Corporation
Bausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States
9 months ago - Bausch + Lomb Corporation
Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results
9 months ago - Bausch + Lomb Corporation
Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry’s Meeting®
9 months ago - Bausch + Lomb Corporation
Bausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular Lens
10 months ago - Bausch + Lomb Corporation
Bausch + Lomb Announces First-Quarter 2024 Results
10 months ago - Bausch + Lomb Corporation
Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting
10 months ago - Bausch + Lomb Corporation
Bausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes
10 months ago - Bausch + Lomb Corporation
Bausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling Programs
10 months ago - Bausch + Lomb Corporation
Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1
a year ago - Bausch + Lomb Corporation
Bausch + Lomb Will Present New Scientific Data and Analyses at the American Society of Cataract and Refractive Surgery Annual Meeting
a year ago - Bausch + Lomb Corporation
Bausch + Lomb Announces Appointment of Karen L. Ling to Board of Directors
a year ago - Bausch + Lomb Corporation
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2023 Results and Provides 2024 Guidance
a year ago - Bausch + Lomb Corporation
Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2023 Financial Results on February 21
a year ago - Bausch + Lomb Corporation
Bausch + Lomb Receives FDA Approval for TENEO™ Excimer Laser Platform for Myopia and Myopic Astigmatism LASIK Vision Correction Surgery
a year ago - Bausch + Lomb Corporation
Bausch + Lomb to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
a year ago - Bausch + Lomb Corporation
Bausch + Lomb Announces Third-Quarter 2023 Results and Raises Full-Year 2023 Guidance
a year ago - Bausch + Lomb Corporation
Bausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Ophthalmology Annual Meeting
a year ago - Bausch + Lomb Corporation
Bausch + Lomb Will Release Third-Quarter 2023 Financial Results on November 1
a year ago - ACCESSWIRE
Bausch Health's Bausch + Lomb Announces Completion of the Acquisition of XIIDRA(R)
a year ago - Bausch + Lomb Corporation